LXRX vs. ARMP
LXRX (Lexicon Pharmaceuticals, Inc.) and ARMP (Armata Pharmaceuticals Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, LXRX returned -17.35%/yr vs -33.51%/yr for ARMP. At a 0.08 correlation, their price movements are largely independent.
Performance
LXRX vs. ARMP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LXRX achieves a 94.78% return, which is significantly higher than ARMP's -40.13% return. Over the past 10 years, LXRX has outperformed ARMP with an annualized return of -17.35%, while ARMP has yielded a comparatively lower -33.51% annualized return.
LXRX
- 1D
- 1.82%
- 1M
- 14.87%
- 6M
- 75.00%
- YTD
- 94.78%
- 1Y
- 73.64%
- 3Y*
- -0.15%
- 5Y*
- -9.60%
- 10Y*
- -17.35%
ARMP
- 1D
- -5.76%
- 1M
- -44.62%
- 6M
- -41.07%
- YTD
- -40.13%
- 1Y
- 59.32%
- 3Y*
- 50.64%
- 5Y*
- 0.05%
- 10Y*
- -33.51%
LXRX vs. ARMP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LXRX Lexicon Pharmaceuticals, Inc. | 94.78% | 55.72% | -51.73% | -19.90% | -51.52% | 15.20% | -17.59% | -37.50% | -32.79% | -28.56% |
ARMP Armata Pharmaceuticals Inc. | -40.13% | 239.46% | -42.90% | 161.29% | -77.37% | 83.59% | -8.16% | 12.53% | -79.57% | -77.05% |
Correlation
The correlation between LXRX and ARMP is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Mar 9, 2011 | 0.08 |
Fundamentals
LXRX:
$995.00M
ARMP:
$138.03M
LXRX:
-$0.07
ARMP:
-$7.78
LXRX:
12.08
ARMP:
30.96
LXRX:
$69.64M
ARMP:
$4.41M
LXRX:
$69.00M
ARMP:
$3.26M
LXRX:
-$20.38M
ARMP:
-$27.14M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LXRX vs. ARMP — Risk / Return Rank
LXRX
ARMP
LXRX vs. ARMP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lexicon Pharmaceuticals, Inc. (LXRX) and Armata Pharmaceuticals Inc. (ARMP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LXRX | ARMP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.53 | ||
| Sortino ratioReturn per unit of downside risk | -0.20 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.23 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.17 | 0.80 | +1.37 |
| Martin ratioReturn relative to average drawdown | 4.52 | 2.22 | +2.30 |
Loading charts...
Drawdowns
LXRX vs. ARMP - Drawdown Comparison
The maximum LXRX drawdown since its inception was -99.91%, roughly equal to the maximum ARMP drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for LXRX and ARMP.
Loading charts...
Drawdown Indicators
| LXRX | ARMP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.91% | -99.98% | +0.07% |
Max Drawdown (1Y)Largest decline over 1 year | -34.09% | -74.59% | +40.50% |
Max Drawdown (3Y)Largest decline over 3 years | -91.83% | -79.22% | -12.61% |
Max Drawdown (5Y)Largest decline over 5 years | -95.25% | -85.70% | -9.55% |
Max Drawdown (10Y)Largest decline over 10 years | -98.48% | -99.68% | +1.20% |
Current DrawdownCurrent decline from peak | -99.32% | -99.92% | +0.60% |
Average DrawdownAverage peak-to-trough decline | -93.29% | -82.90% | -10.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.33% | 26.75% | -10.42% |
Volatility
LXRX vs. ARMP - Volatility Comparison
The current volatility for Lexicon Pharmaceuticals, Inc. (LXRX) is 19.33%, while Armata Pharmaceuticals Inc. (ARMP) has a volatility of 29.67%. This indicates that LXRX experiences smaller price fluctuations and is considered to be less risky than ARMP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LXRX | ARMP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.33% | 29.67% | -10.34% |
Volatility (6M)Calculated over the trailing 6-month period | 60.04% | 74.39% | -14.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.53% | 143.87% | -64.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 97.94% | 114.45% | -16.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.34% | 110.59% | -13.25% |
Dividends
LXRX vs. ARMP - Dividend Comparison
Neither LXRX nor ARMP has paid dividends to shareholders.
Financials
LXRX vs. ARMP - Financials Comparison
This section allows you to compare key financial metrics between Lexicon Pharmaceuticals, Inc. and Armata Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
LXRX and ARMP have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARMP has higher volatility (29.67%) compared to LXRX (19.33%). In terms of maximum drawdown, LXRX dropped -99.91% vs ARMP's -99.98%.
LXRX currently has the higher Sharpe Ratio (0.94 vs 0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LXRX and ARMP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer